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A B S T R A C T   
Ethnopharmacological relevance: Salvia chudaei Batt. & Trab. from Algeria is traditionally used to relieve several dysfunctions, including inflammatory and pain-related 
situations. 
Aim of the study: This work aimed to confirm scientifically the referred properties. For that, the phenolic composition and antioxidant activity were evaluated as well 
as acute toxicity, anti-inflammatory and analgesic effects of different doses of the infusion of S. chudaei aerial parts. 
Materials and methods: Infusion of aerial parts of S. chudaei was prepared and screened for phenolic composition by generalized methods TPC and TFC then by LC- 
DAD-ESI/MSn. DPPH and FRAP were used to evaluate antioxidant activity. Using mice, acute toxicity, anti-inflammatory by carrageenan-induced paw edema, and 
analgesic by acetic acid-induced writhing and formalin-induced pain activities were tested. 
Results: The infusion showed 2018 mg GAE/100g DW of phenolics and 1956 mg ECE/100g DW of flavonoids. Phenolic profile by LC-DAD-ESI/MSn revealed the 
presence of ten compounds: syringic acid hexoside derivative, kaempferol-O-diglucuronide, kaempferol-O-deoxyhexoside-hexoside, kaempferol-O-glucuronide, 
apigenin-O-diglucuronide, caffeic acid, 4-O-caffeoylquinic acid, eriodictyol-O-glucuronide, rosmarinic acid hexoside, and rosmarinic acid. This acid was the 
major compound representing 54% of the total content of the identified compounds and an absolute content of 18 mg/g of extract. Additionally, the infusion 
exhibited a good antioxidant activity (DPPH: 81 μmol TE/g DW, FRAP: 438 μmol FSE/g DW). By oral administration to mice, the infusion showed a significant 
(p<0.05) dose-dependent reduction of carrageenan-induced inflammation and inhibition of formalin-induced pain (late and early phase) and acetic acid-induced 
writhing compared with the control. On the other hand, infusion up to 8 g/kg b.w. showed no signs of toxicity or mortality. 
Conclusion: This study reveals, for the first time, that the infusion of the aerial parts of S. chudaei is not toxic in a single dose and has remarkable antioxidant, anti- 
inflammatory, and analgesic activities, supporting the use of this species in folk medicine.   
1. Introduction 
The use of traditional medicines, particularly herbal medicines, has 
been widely increasing during the recent decades (Popović et al., 2016). 
Since the old times, people used medicinal plants for healing and other 
health care, probably due to their wide availability, as well as the high 
cost and difficult access to drugs in some regions of the world. Their use 
represents also the preservation of the cultural heritage, considering the 
traditional medicine practice as a part of peoples culture (Van Wyk and 
Wink, 2018). 
Lamiaceae (Labiatae) family that comprises 236 genera and about 
6900–7200 species (Stevens, 2016; Tamokou et al., 2017) contains 
many species with medicinal virtues (Ruiz-Vargas et al., 2019; Saad 
et al., 2016; Sreeja et al., 2018). Salvia L. is the largest genus of this 
family (900–1000 species) (Walker et al., 2004); several Salvia species 
have very interesting pharmacological properties, namely antioxidant 
(Esmaeili and Sonboli, 2010), anti-diabetic (Flores-Bocanegra et al., 
2017), analgesic (Simon-Arceo et al., 2017), in vitro/in vivo 
anti-inflammatory activity (Akram et al., 2015), and anti-Alzheimer 
effects (Senol et al., 2017), which in several cases are attributed to 
secondary metabolites, especially phenolic compounds. 
Phenolic compounds include a multitude of molecules (e.g. flavo-
noids, phenolic acids, stilbenes, tannins, and lignans), responsible for 
the main organoleptic properties of plant derived-foods and beverages, 
and contributing also to the vegetables and fruits nutritional properties 
(Tapas et al., 2008). Simultaneously, phenolic compounds are getting a 
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large interest thanks to their association with many bioactivities, 
probably related to their antioxidant power (Shahidi and Yeo, 2018). 
S. chudaei is an endemic plant of the central Sahara massif (Ozenda, 
1991), known as Aouit in Tamahaq (indigenous language of the Touareg 
population in the South of Algeria) and as Tagrouft in Arabic. This plant 
is used to relieve numerous diseases and disorders such as ulcer, diar-
rhea, rheumatism, kidney diseases, dysmenorrhea, abdominal pain, 
spasms, urinary retention, urinary tract infection, and prostate pain, 
consumed as infusion, decoction, or powder (Hammiche and Maiza, 
2006; Ramdane et al., 2015; Sekkoum et al., 2011). However, besides 
the use of this plant to relieve dysfunctions, no studies were carried out 
about its acute toxicity, anti-inflammatory activity, analgesic effect as 
well as its phenolic compound profile. Yet, some studies reported the 
composition of essential oil from aerial parts along with the antimicro-
bial and antioxidant activities of some organic extracts of S. chudaei 
(Hammoudi et al., 2017a; Krimat et al., 2015a, 2015b). 
In order to confirm some of the reported healing virtues of S. chudaei 
infusion obtained from aerial parts, this research aimed to identify and 
quantify the molecules responsible for those medicinal benefits. To do 
that, different doses of infusion were tested in what concerns its toxicity, 
in vivo analgesic and anti-inflammatory effects, as well as its antioxidant 
activity, total phenolic and flavonoid contents, and phenolic profile by 
Liquid Chromatography coupled to Diode Array Detector and Electro-
spray Ionization tandem Mass Spectrometry (LC-DAD-ESI/MSn). 
2. Materials and methods 
2.1. Plant material 
S. chudaei was harvested in January 2017 in the Ilamen station 
(longitude: 005◦ 29 30.6 E, latitude: 23◦ 14 26.9 N, altitude: 2055 m), 
located in the region of Tamanrasset in Southern Algeria. The authen-
tication of the plant species was certified by the Higher National Agro-
nomic School, El Harrach, Algiers, Algeria, according to Quezel and 
Santa (1963). A Standard specimen is conserved in the herbarium of 
Montpellier (voucher N◦: MPU 010317). The plant aerial parts were air 
shade dried, at room temperature (22 ± 2 ◦C), then ground in a mill to 
small particles for further use. 
2.2. Preparation of the infusion 
The infusion (5% w/v) was prepared by adding boiling deionized 
water to the sample powder and left to stand for 5 min. Three inde-
pendent extractions were prepared, the content filtered via Whatman 
paper N◦3. The prepared infusion was thereafter used in the assays. For 
the LC-DAD-ESI/MSn analysis, the infusion extract was firstly lyophi-
lized then dissolved in methanol/water (80:20, v/v). 
2.3. Experimental animals 
20–30g Swiss albino mice (NMRI) purchased from the Pasteur 
Institute of Algiers (Algeria) were acclimatized for 2 weeks before ex-
periments, housed at 24 ± 1 ◦C, 50 ± 5% humidity, and 12/12 h light- 
dark cycle. They were fed with rodent chow from the Animals Food 
National Office (ONAB) Bejaia, Algeria, and had free access to water. 
The animals were handled following the care and use of the laboratory 
animals guide (Council, 2010). All procedures involving animals were 
approved by the University Animal Experiment Ethics Committee 
(approval ref no. 162/2011/8). 
2.4. Acute oral toxicity 
The toxicity was evaluated in animals of both sexes, according to the 
Organization for Economic Co-operation and Development (OECD) 
guideline 423 with slight modifications (OECD, 2001). 3 groups of NMRI 
mice, consisting of 3 males and 3 females each, were used for this 
evaluation. Each group received 0.5 mL of S. chudaei infusion, in 
different doses as follows: group 1–2000 mg/kg b.w.; group 2–3000 
mg/kg b.w.; and group 3–5000 mg/kg body weight (b.w.). After 
administration, the animals were carefully observed in the first 4 h for 
any abnormal behavior or toxicity sign and after, daily during 14 days to 
observe mortality. 
2.5. Analgesic activity 
To determine the analgesic activity two tests were evaluated: the 
Writhing and Formalin tests. 
2.5.1. Writhing test 
The writhing test using acetic acid (Liu et al., 2015) proceeded as 
follows. 5 groups, of 6 mice each, were used in this evaluation, the 
different groups receive orally as follows: group 1–0.5 mL saline solu-
tion; group 2–0.5 mL of paracetamol® at 100 mg/kg b.w.; group 3, 4, 
and 5–0.5 mL of S. chudaei infusion at 250, 500 and 1000 mg/kg b.w., 
respectively. After 30 min they were intraperitoneally injected with 200 
μl of 0.6% acetic acid. 5 min after, the abdominal constrictions number 
was counted for 15 min. The results were expressed as protection per-
centage using the following formula: 
Protection%= [(NCc − NCt) /NCc]x100  
where NCc represents constrictions number in control (saline solution) 
and NCt the constrictions number in tested drug (paracetamol® and the 
infusion at different doses). 
2.5.2. Formalin test 
The antinociceptive activity of the sample extracts was assessed by 
the formalin test (Hunskaar et al., 1985). For that, 5 groups containing 5 
mice each were formed. The different groups received per os: 1–0.5 mL of 
saline; 2–50 mg/kg b.w. paracetamol®; 3–250 mg/kg b.w. of the infu-
sion; 4–500 mg/kg b.w. of the infusion; 5–1000 mg/kg b.w. of the 
infusion. After 1h, 20 μl of formalin (2.5% formaldehyde in 0.9% NaCl 
saline) were subcutaneously injected into the right paw dorsal surface. 
Immediately, the licking and biting time of the injected paw was 
recorded for 5 min (early phase), and after 15–30 min (late phase). The 
protection percentage was calculated as follows: 
Protection%= [(Tc − Tt) /Tc]x100 
in which, Tc represents the time of licking and biting in the control 
(saline solution), Tt the time of licking and biting in the tested drug 
(paracetamol® and the infusion at different doses). 
2.6. Anti-inflammatory activity 
The evaluation of the anti-inflammatory activity was carried out by 
paw edema provocation with carrageenan (Levy, 1969). 1% carra-
geenan in saline solution (0.9% NaCl), was injected into the mice right 
hind paw plantar surface. In this experiment 5 groups of 6 mice each 
were used; the control group received 0.5 mL of saline solution; the 
reference group received 50 mg/kg b.w. of diclofenac; and the other 
three groups received 250, 500, and 1000 mg/kg b.w. of S. chudaei 
infusion. The edema was induced after 30 min of the drug administra-
tion. 4 h later, mice were sacrificed by cervical dislocation and imme-
diately both right and left hind paws were cut at the talocrural joint and 
weighted. 
The results are expressed as inhibition edema percentage (IEP) using 
the formula below: 
IEP= [(EPc − EPt) /EPc]x100 
in which, EP represents edema percentage in control (c, saline so-
lution) and in tested drug (t, diclofenac and infusion at different doses). 
The edema percentage (EP) is calculated as follows: 
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EP= [(RPW − LPW) / LPW]x100  
where RPW representing the right paw weight and LPW the left paw 
weight. 
2.7. Total phenolic content (TPC) 
Total phenolics were determined by spectrophotometry (BioTek In-
struments, Inc.) (Alves et al., 2010) with some modifications. Briefly, 30 
μl of the sample were mixed with 150 μl of Folin-Ciocalteu reagent 
(1:10, v/v) and 120 μl of sodium carbonate (7.5%, m/v). The mixture 
was then incubated during 15 min at 45 ◦C, followed by 30 min at room 
temperature, protected from light. The absorbance was measured at 765 
nm. The calibration curve was prepared with gallic acid (5–80 mg/L; r =
0.9998) and the results expressed as mg of gallic acid equivalents/100g 
of sample dry weight (mg GAE/100g DW). 
2.8. Total flavonoid content (TFC) 
TFC were determined according to Costa et al. (2014). In brief, 100 
μL of sample was mixed with 400 μL distilled water and 30 μL NaNO2 
5%; after 5 min at room temperature 30 μL AlCl3 were added to the 
mixture; 1 min after, 200 μL NaOH 1M and 250 μL distilled water were 
added. Absorbance measurements were performed at 510 nm. A cali-
bration curve was prepared with epicatechin (2.5–400 mg/L; r =
0.9946), and results expressed as mg of epicatechin equivalents/100g of 
sample dry weight (mg ECE/100g DW). 
2.9. Antioxidant activity 
2.9.1. DPPH• radical scavenging activity 
This method is based on the reduction of the free radical DPPH• (2,2- 
diphenyl-1-picrylhydrazyl) by the antioxidants present in the infusion. 
The evaluation of the scavenging power was performed according to 
Costa et al. (2014), with some modifications. Briefly, 30 μl of infusion 
was mixed with 270 μl of DPPH• (6.0 × 10− 5 mol/L in ethanol). The 
absorption decrease of DPPH• was measured at 525 nm in intervals of 2 
min, in order to observe the kinetics reaction. The reaction endpoint was 
reached in 20 min. The results were expressed as mg trolox equivalent/g 
of sample dry weight (mg TE/g DW) using a standard curve (5.62–75.87 
mg/L, r = 0.9978). 
2.9.2. Ferric reducing antioxidant power (FRAP) 
The FRAP assay was carried out according to Costa et al. (2014). In 
brief, 35 μl of sample was mixed with 265 μl of FRAP reagent (0.3 M 
acetate buffer, 10 mM TPTZ solution, and 20 mM of ferric chloride). The 
mixture was incubated for 30 min at 37 ◦C in dark. Absorbance was 
measured at 595 nm. A calibration curve was prepared with ferrous 
sulfate (25–500 μmol/L; r = 0.9997) and the results expressed as mg of 
ferrous sulfate/g of sample DW (mg FSE/g DW). 
2.10. LC-DAD-ESI/MSn profiling of phenolic compounds 
LC-DAD-ESI/MSn (Dionex Ultimate 3000 UPLC, Thermo Scientific, 
San Jose, CA, USA) was used for the phenolic profile determination, 
according to Bessada et al. (2016) protocol. The obtained extract was 
lyophilized then dissolved in methanol:water (80:20, v/v) at 10 mg/mL 
concentration. Compounds were detected using a DAD with (370, 330, 
and 280 nm) as favored wavelengths and MS in negative mode, via a 
Linear Ion Trap LTQ XL mass spectrometer (Thermo Finnigan, San Jose, 
CA, USA) coupled to ESI source. The compounds identification was 
based on their chromatographic behavior and UV–vis, and mass spectra, 
comparing with standards and reported data in literature via Xcalibur® 
data system (Thermo Finnigan, San Jose, CA, USA). The quantification 
was based on the UV–vis signal using the calibration curve for the 
available standards or the most similar for the non-available ones. 
Values were expressed as mg/g of extract. 
2.11. Statistical analysis 
Results were presented in mean ± standard deviation. Comparisons 
between groups were performed by one-way ANOVA (analysis of vari-
ance) followed by post-hoc Tukey’s HSD (Honestly Significant Differ-
ence) test. p<0.05 was considered statistically significant. All statistics 
were carried out using R statistical software (version 3.6.0). 
3. Results and discussion 
3.1. Phytochemical analysis 
In this work, we sought to investigate the antioxidant, anti- 
inflammatory, and analgesic activities of S. chudaei infusion from the 
region of Tamanrasset (south of Algeria). It is well-known that estab-
lishing a correlation between phytochemical composition and potential 
biological activities has an essential role to figure out the potential 
compounds responsible for those activities. Hence, we have performed 
profiling and quantification of S. chudaei infusion phenolic compounds. 
The infusion prepared at 5% rate yielded 15.48 ± 0.14% (w/w) of 
extract. Table 1 presents the Total Phenolic and Total Flavonoid con-
tents determined spectrophotometrically. In what concerns TPC, 
S. chudaei infusion showed 2018.48 ± 65.93 mg GAE/100g DW. Ham-
moudi et al. (2017b) reported for the same species 187.2 ± 4.68 and 
292.1 ± 3.81 mg GAE/100g DW for 80% ethanol-water and Soxhlet 
extracts, respectively. Moreover, S. chudaei infusion TPC, determined in 
this study, is superior or close regarding TPC of some other Salvia species 
infusions and aqueous extracts. This is the case of S. officinalis 431 ± 37 
mg GAE/100g DW (Hernández-Saavedra et al., 2016), S. tomentosa 
349.72 ± 1.27 and S. fruticosa 396.31 ± 1.89 mg GAE/100g DW 
(Erdogan-Orhan et al., 2010), S. cadmica 940.93 ± 6.97 mg GAE/100g 
DW (Kocak et al., 2016), and S. jurisicii 14.27 ± 0.09 mg GAE/g DW 
despite the 24 h maceration time and the use of ultrasound bath 
(Alimpić et al., 2017). Even when methanol-water 70% and ethanol 
were used as solvents, which are known to have a high recovery, the 
phenolic compounds rate was 1981.56 ± 32.13 mg GAE/100g (Poyraz 
et al., 2017). As exception, the aqueous maceration of S. officinalis 
during 24 h obtained 32 mg GAE/g DW (Bahri et al., 2019), which was 
superior to the values from the presented work. 
Concerning Total Flavonoids Content, S. chudaei infusion showed 
1955.59 ± 126.12 mg ECE/100g DW. Several other Salvia infusions and 
aqueous extracts showed less TFC values, this is the case of: S. officinalis 
892 ± 26 mg CE/100g DW (Hernández-Saavedra et al., 2016), 
S. fruticosa 107.14 ± 2.47 mg CE/g DE (Altay, 2015), S. aramiensis 
118.85 ± 4.47 mg CE/g DE (Karatoprak et al., 2020); methanolic ex-
tracts of S. sclarea, S. atropatana, S. ahendica, S. hydrangea, S. xan-
thocheila, S. macrosiphon, S. glutinosa, S. chloroleuca, and S. ceratophylla 
ranged from 2.2 ± 0.2 to 36.2 ± 0.5 mg CE/g DE (Loizzo et al., 2014), 
S. officinalis 11.2 mg CE/g DE (Ghorbanpour, 2015). 
The comparison of TPC and TFC values of S. chudaei infusion with 
other reported results allows having an idea about the richness in 
phenolic compounds of S. chudaei infusion. Nevertheless, it is important 
to identify the type of phenolic compounds present in the sample, here 
identified by LC-DAD-ESI/MSn. Table 2 shows the results obtained with 
Table 1 
TPC, TFC, DPPH•, and FRAP values of S. chudaei infusion.  
Bioactive compounds TPC mg GAE/100g DW 2018.48 ± 65.93 
TFC mg ECE/100g DW 1955.59 ± 126.12 
Antioxidant activity DPPH• μmol TE/g DW 81.31 ± 7.79 
FRAP μmol FSE/g DW 437.53 ± 17.32 
Mean ± SD, n = 3, mg GAE: gallic acid equivalent; ECE: epicatechin equivalent; 
TE: Trolox equivalent; FSE: ferrous sulfate equivalent; DW: dry weight. 
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such methodology. 
The compounds identification was achieved through the UV–vis 
behavior and mass spectra fragmentation in negative ion mode, 
comparing with standards, when available, and Xcalibur® data system. 
According to literature review, no work on the profiling of phenolic 
compounds concerning S. chudaei from the Tamanrasset region (south-
ern Algeria) or elsewhere, has been reported previously. Ten compounds 
from two classes, phenolic acids and flavonoids, were identified. Among 
the phenolic acids, one hydroxybenzoic acid (syringic acid hexoside 
derivative (2)) and four hydroxicinnamic acids (4-O-caffeoylquinic acid 
(1), caffeic acid (3), rosmarinic acid hexoside (7), and rosmarinic acid 
(10)) were detected. For the flavonoids class, five compounds were 
putatively identified, being three flavonols (kaempferol-O-diglucur-
onide (4), kaempferol-O-deoxyhexoside-hexoside (8), and kaempferol- 
O-glucuronide (9)), one flavanone (eriodictyol-O-glucuronide (5)), 
and one flavone (apigenin-O-diglucuronide (6)). 
Quantitatively, the rosmarinic acid was the major compound with an 
amount of 18.3 ± 0.5 mg/g of extract, followed by another rosmarinic 
acid derivative, the rosmarinic acid hexoside with 6.58 ± 0.05 mg/g of 
extract, representing together about 73% of identified phenolics. 4-O- 
caffeoylquinic acid, kaempferol-O-diglucuronide, and apigenin-O- 
diglucuronide are present in considerable amounts of 1.783 ± 0.005, 
1.42 ± 0.03, and 1.40 ± 0.02 mg/g of extract, respectively. The less 
abundant were eriodictyol-O-glucuronide, caffeic acid, and syringic acid 
hexoside derivative with 0.81 ± 0.02, 0.74 ± 0.03, and 0.51 ± 0.02 mg/ 
g of extract, respectively. The phenolic compounds extracted are almost 
all in the glycosylated form; glycosylation increases the solubility in 
water, the stability, and the promotion of the biological activity of 
various natural compounds including phenolics (Moon et al., 2017; 
Torres et al., 2011). 
Several studies about phenolic compounds in Salvia species, using 
different extraction solvents (water, methanol, and ethanol), are in 
agreement with the present results. They reported rosmarinic acid as the 
dominant phenolic compound. This is the case of S. cadmica (Kocak 
et al., 2016), S. officinalis (Pedro et al., 2016), S. brachyantha and 
S. aethiopis (Tohma et al., 2016), and S. farinacea Var. Victoria Blue 
(Afonso et al., 2019). Nevertheless, some researchs have highlighted 
other abundant compounds than rosmarinic acid: luteolin-glucuronide 
in the infusion of S. officinalis (Martins et al., 2015; Schnitzler et al., 
2008), and decoction and methanol/water extract of S. officinalis 
(Martins et al., 2015), kaempferol in an ethanolic extract of S. microstegia 
(Tohma et al., 2016). These molecules may function as genus markers of 
this species. Several factors can affect the chemical composition of 
plants, for example the harvesting season, geographical origin, and the 
extraction method (Moon et al., 2017). The reported findings indicate 
that S. chudaei can be a good source of rosmarinic and caffeic acid, as 
well as apigenin and kaempferol. 
3.2. Antioxidant activity 
Two colorimetric methods, DPPH• and FRAP, generally used to 
evaluate the antioxidant capacity of natural products, were performed 
with the same objective in this study. DPPH• assay is widely used to 
assess the ability of the compounds as free-radical scavengers or 
hydrogen donors to form stable non-radical DPPH• molecules. The re-
sults from the antioxidant activity evaluation are presented in Table 1, 
with S. chudaei infusion DPPH• activity of 20.35 ± 1.95 mg TE/g DW 
(81.31 ± 7.79 μmol TE/g DW). The DPPH• scavenging activity was 
higher than the reported by Kocak et al. (2016) for the infusion, and 
even for ethyl acetate and methanol extracts of S. Cadmica (40.51 ±
0.05, 5.93 ± 0.13, and 54.71 ± 0.05 μmol TE/g DW, respectively). Also, 
the reported results of Erdoğan et al. (2014) were inferior, for the 
methanolic extract of S. fruticosa leaves from three regions, with values 
ranging from 450.51 ± 1.19 to 287.57 ± 2.16 (μmol TE/100g DW). The 
determined value of S. chudaei infusion in this activity was higher than 
the ones determined in many plant infusions traditionally used in 
Andes/South America: Adesmia melanthes Phil. (1523 μmol TE/L); 
Chuquiraga atacamensis K. (77 μmol TE/L); Senecio nutans (609 μmol 
TE/L); Fabiana densa (1026 μmol TE/L); Fabiana squamata (74 μmol 
TE/L); Lampaya medicinalis (1045 μmol TE/L); Azorella compacta (459 
μmol TE/L); Opuntia ignescens (6 μmol TE/L); Baccharis tola (67 μmol 
TE/L); Parastrephia lepidophylla (265 μmol TE/L); Acantholippia deserti-
cola (222 μmol TE/L); and Parastrephia lucida (541 μmol TE/L) (Rojo 
et al., 2009). However, S. officinalis from Brazilian market, extracted 
with a solvent solution of acetone/ultrapure water/glacial acetic acid 
(70:28:2, v/v) had higher DPPH• activity (2.59 ± 0.17 g TE/100g DW) 
(Fernandes et al., 2016) than the infusion in evaluation. 
The FRAP assay consists in TPTZ-Fe (III) complex reduction to TPTZ- 
Fe (II) by the compounds present in tested samples. The reducing power 
is a useful determinant of potential antioxidant activity. S. chudaei 
infusion showed a value of 437.53 ± 17.32 μmol FSE/g DW, this value 
seems better than the ones previously reported by other authors. Ac-
cording to Grzegorczyk-Karolak and Kiss (2018) a FRAP activity be-
tween 890 and 1575 μmol FSE/g extract were obtained for decoction, 
infusion, and ethanolic extracts of S. viridis. Alimpić et al. (2017) eval-
uated the decoction and ethanolic extract of S. jurisicii (277.14 ± 8.6, 
Table 2 
Retention time (Rt), maximum absorption wavelengths in the visible region (λmax), mass spectral data, concentration, and tentative identification of Salvia chudaei 
infusion phenolic compounds.  
Peak Rt (min) λmax (nm) [M-H]-(m/z) MS2 (m/z) Tentative identification Concentration (mg/g) of extract 
1 6.59 321 353 191(11),179(45),173(100),135(5) 4-O-Caffeoylquinic acid (Cryptochlorogenic acid) 1.783 ± 0.005 
2 7.53 283 403 241(70),197(100),179(5),135(5) Syringic acid hexoside derivative 0.51 ± 0.02 
3 10.07 323 179 135(100) Caffeic acid 0.74 ± 0.03 
4 13.66 340 637 285(100) Kaempferol-O-diglucuronide 1.42 ± 0.03 
5 15.45 285 595 287(100) Eriodictyol-O-glucuronide 0.81 ± 0.02 
6 16.2 330 621 269(100) Apigenin-O-diglucuronide 1.40 ± 0.02 
7 17.29 319 521 359(100),197(5),179(5),161(5),135(5) Rosmarinic acid hexoside 6.58 ± 0.05 
8 18.66 342 593 285(100) Kaempferol-O-deoxyhexoside-hexoside 1.235 ± 0.003 
9 18.95 341 461 285(100) Kaempferol-O-glucuronide 1.24 ± 0.06 
10 21.97 328 359 197(100),179(34),161(19),135(5) Rosmarinic acid 18.3 ± 0.5      
TPA 27.9 ± 0.5      
TF 6.1 ± 0.1      
TPC 34.0 ± 0.5 
*It was not possible to identify any phenolic compounds in the sample. Standard calibration curves: apigenin-7-O-glucoside (y = 10683x– 45794, R2 = 0.996, LOD =
136.95 μg/mL and LOQ = 414.98 μg/mL), caffeic acid (y = 388345x + 406369, R2 = 0.9939, LOD = 8.57 μg/mL and LOQ = 25.97 μg/mL), chlorogenic acid (y =
168823x – 161172, R2 = 0.9999, LOD = 0.83 μg/mL and LOQ = 2.50 μg/mL), naringenin (y = 18433x + 78903, R2 = 0.9998, LOD = 18.66 μg/mL and LOQ = 56.55 
μg/mL), rosmarinic acid (y = 191291x– 652903, R2 = 0.999, LOD = 3.70 μg/mL and LOQ = 11.22 μg/mL), quercetin-3-O-glucoside (y = 34843x– 160173, R2 =
0.9998, LOD = 17.01 μg/mL and LOQ = 51.54 μg/mL), and syringic acid (y = 376056x + 141329, R2 = 0.9995, LOD = 2.37 μg/mL and LOQ = 7.18 μg/mL). TPA: total 
phenolic acids, TF: total flavonoids, TPC: total phenolic compounds. 
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and 279.44 ± 8.45 μmol FSE/g extract, respectively) obtained lower 
values than the reported in this work. Another study of nine Salvia 
species, using methanol as extraction solvent, showed a lower FRAP 
activity: S. sclarea L. (160.1 ± 1.5 μmol FSE/g extract); S. atropatana 
(Boiss.) Buhse Bunge (20.6 ± 7.3); S. ahendica (Boiss.) Buhse (8.9 ± 4.1); 
S. hydrangea DC. (195.9 ± 5.4); S. xanthocheila Boiss. ex Benth. (14.4 ±
4.6); S. macrosiphon Boiss. (10.2 ± 3.4); S. glutinosa L. (422.0 ± 9.8); 
S. chloroleuca Rech.f. & Aell. (12.9 ± 0.8) and S. ceratophylla L. (290.7 ±
6.0 μmol FSE/g extract) (Loizzo et al., 2014). 
In both tests, DPPH• and FRAP, S. chudaei infusion exhibit excellent 
values for antioxidant activity, taking into account the reported results 
in the literature. It is also well-known that this feature has a strong 
correlation with TPC (Fernandes et al., 2016; Grzegorczyk-Karolak and 
Kiss, 2018; Kamatou et al., 2010), demonstrating the strong involvement 
of phenolics in antioxidant activity. Indeed, rosmarinic acid, 
non-exhaustively, could be responsible for the high antioxidant power of 
the sample. Rosmarinic acid extracted from Perilla frutescens leaves has 
displayed a higher DPPH• radical scavenging activity (SC50 = 5.5 ± 0.2 
μg/mL) than P. frutescens leaves extract (10.8 ± 0.1 μg/mL). Addition-
ally, rosmarinic acid SC50 compared to standards was slightly close to 
that obtained by Trolox (5.1 ± 0.1 μg/mL) and higher than that of 
butylated hydroxytoluene (BHT) (6.6 ± 0.3 μg/mL) (Zhu et al., 2014). 
Moreover, rosmarinic acid showed the greatest activity potential among 
various phenolic acids tested in many antioxidant methods; caffeic acid 
has also shown an excellent antioxidant activity (Sevgi et al., 2015). Lu 
and Foo (2001) working on S. officinalis polyphenols have found that 
caffeic acid and rosmarinic acid derivatives exhibited potent antioxidant 
activity than flavone glycosides, and suggested that this strong activity 
could be due to their catechol moieties and conjugated unsaturation 
presence. 
Reactive oxygen species (ROS) play a crucial role in the inflamma-
tory response. They proceed as inflammatory mediators and signaling 
molecules produced by polymorphonuclear neutrophils (PMNs). Be-
sides, reactive nitrogen species (RNS) can be rapidly formed by combi-
nation of nitrogen oxide (NO) and superoxide (O2.-). Unfortunately, this 
reaction is 3–4 faster than the dismutation of superoxide by the super-
oxide dismutase (SOD) (Mittal et al., 2014). The unbalance between 
ROS/RNS production and deletion may probably damage biomolecules 
(DNA, lipids, amino acid …), perturb cellular thiol levels, and deregulate 
cellular signaling pathways implicated in various diseases (Fransen 
et al., 2012; Mungli et al., 2009). 
3.3. Acute toxicity 
Table 3 displays the results (mortality and toxicity sign) of the 
determination of acute toxicity of the infusion of S. chudaei aerial parts. 
The different infusion tested doses (2000, 3000, and 5000 mg/kg b.w.) 
did not show any toxicity sign (salivation, sleep, diarrhea, coma, etc.) in 
the first 4 h after oral administration. In the 14 days after, no mortality 
was observed for either male or female mice. This feature allows 
supposing the safety of S. chudaei infusion at the tested doses. Likewise, 
it is expected that LD50 (lethal dose causing 50% of tested animals 
death) will be superior to 5000 mg/kg b.w., taking into account the 
absence of any toxicity sign/mortality. Nevertheless, it will be very 
interesting to complete this test with a sub-acute oral toxicity test 
including biochemical and histological studies. 
3.4. Anti-inflammatory activity 
The anti-inflammatory effect of S. chudaei infusion was evaluated via 
carrageenan test, one of the most popular tests to screen the anti- 
inflammatory properties of drugs and plant extracts. Table 4 shows 
the effect of three doses of S. chudaei infusion orally administered on 
mice paw induced inflammation. The doses (250, 500, and 1000 mg/kg 
b.w.) of S. chudaei infusion and diclofenac® (50 mg/kg b.w.) reduced 
significantly (p<0.001) the paw edema after 4 h of administration, 
comparing to the control. The lower edema percentage was obtained 
with the more concentrated infusion (1000 mg/kg b.w.) with an inhi-
bition percentage of 58%, showing a strong anti-inflammatory effect. 
This effect was better than the effect obtained with diclofenac® (50 mg/ 
kg b.w.) that allowed an inhibition percentage of 53%. The other 
assayed infusion doses (250 and 500 mg/kg b.w.) allowed obtaining 
lower percentages but not so far from the mentioned values (45 and 
48%, respectively). Many Salvia species have been screened for their 
anti-inflammatory activity (Akram et al., 2015; Kamatou et al., 2010). 
Choi et al. (2018) reported that some caffeic acid derivatives, especially 
rosmarinic acid methyl ester, extracted from S. miltiorrhiza exhibit 
potent anti-inflammatory effects through the inhibition of inflammatory 
mediators (COX-2: cyclooxygenase-2, NO: nitric oxide, and iNOS: 
inducible nitric oxide synthase) and the induction of HO-1 (heme 
oxygenase-1) which have for mission to inhibit the oxidative stress. On 
the other hand, Kamatou et al. (2010) tested the anti-inflammatory 
potential of sixteen Salvia species, reporting a poor inhibition of the 
5-lipoxygenase enzyme (IC50 > 100 μg/mL), with exception of one 
species that displayed a moderate inhibition. The administration of 
Rosmarinus officinalis extract and its rosmarinic acid in similar dose (25 
mg/kg b.w.) resulted the same paw edema inhibition of about 60% 
volume reduction compared with control (Rocha et al., 2015). 
Taking into account the results of the phytochemical analysis per-
formed in this study revealing the presence of rosmarinic acid as the 
main compound, and its described anti-inflammatory and antioxidant 
potential, it is expectable the ability of S. chudaei infusion to inhibit paw 
edema. This activity has rosmarinic acid as the responsible, probably 
due to its action on the COX-2 inhibition pathway. Many studies involve 
the flavonoids in the in vitro and in vivo anti-inflammatory properties. 
This is the case of apigenin, a compound with a significant presence in 
the studied sample, that is linked to its ability to inhibit cyclooxygenase 
and lipoxygenase enzymes (Kim et al., 2004; Narayana et al., 2001). 
3.5. Analgesic tests 
3.5.1. Acetic acid-induced writhing test 
The analgesic effect of S. chudaei infusion was evaluated by the acetic 
acid test and Table 5 summarizes the obtained results. All tested doses 
(250, 500, and 1000 mg/kg b.w.) showed highly significant (p<0.001) 
Table 3 
Effect of S. chudaei infusion on acute oral toxicity in mice.  
Dose mg/kg b.w. Animals Mortality Toxicity sign 
Control (saline) 3 male – – 
3 female – – 
2000 3 male – – 
3 female – – 
3000 3 male – – 
3 female – – 
5000 3 male – – 
3 female – –  
Table 4 
Effect of S. chudaei infusion on carrageenan-induced paw edema in mice.  
Group (n = 5) Dose (mg/kg b. 
w.) 




0.5 (mL) 42.00 ± 2.12 a – 
Diclofenac® 50 19.79 ± 1.15 
bd 
52.91 
Infusion 250 23.20 ± 1.11 c 44.79  
500 21.64 ± 1.61 
bc 
48.51  
1000 17.55 ± 1.48 d 58.25 
Mean ± SD, different letters indicate statistically significant differences between 
groups (p<0.05). 
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reduction of abdominal constrictions, comparing to the control. The 
decreasing number of constrictions is dependent of the tested dose, 
meaning that the highest dose (1000 mg/kg b.w.) has the least number 
of constrictions (15, with an inhibition percentage of 69%). Paraceta-
mol® 100 mg/kg b.w. showed also a highly significant (p<0.001) 
reduction regarding the control (51% with 24 constrictions). It is worth 
noting that the infusion doses 500 and 1000 mg/kg b.w. exhibited 
higher protection percentages (56% and 69%, respectively) than para-
cetamol® (51%). The less concentrated infusion sample presented in-
hibition percentage slightly lower (45.38) than paracetamol®. 
Nevertheless, the presented values give to S. chudaei infusion a potential 
analgesic effect. 
In the acetic acid test, after intraperitoneal injection of the acid, an 
increase in the number of polymorphonuclear neutrophils into the 
peritoneal fluid was detected; this may raise the release of several in-
flammatory mediators, leading to the inflammatory pain in the inflam-
mation site through nociceptive neurons stimulation. The acetic acid 
activates directly visceral and somatic nociceptors, as a general (non- 
selective) nociceptive model. It is a sensitive test to evaluate the pe-
ripheral analgesic action of drugs (Abbate et al., 1990; Le Bars et al., 
2001; Satyanarayana et al., 2004). 
3.5.2. Formalin test 
The antinociceptive action of S. chudaei infusion was determined by 
measuring the spent time in licking/biting mice paw, after formalin 
injection, and the results are displayed in Table 6. Three doses (250, 500, 
and 1000 mg/kg b.w.) of infusion were used to evaluate the neurogenic 
(early) and inflammatory (late) phases. In both phases, the licking/ 
biting time was dose-dependent, decreasing with the dose increasing. In 
the early phase, the licking/biting time of the tested doses decreased 
significantly, comparing to the control (Table 6). The highest protection 
percentage was exhibited by the 1000 mg/kg b.w. dose (61%). This 
value is near to the one presented by paracetamol® 50 mg/kg b.w. 
(63%). In the late phase, a significant decrease in licking/biting time 
was also observed in all tested doses, comparatively to control, and in a 
similar way as described for the early phase. The 1000 mg/kg b.w. 
infusion dose showed a protection percentage of 58%, lower than the 
paracetamol 50 mg/kg b.w. protection percentage (65%) but an inter-
esting antinociceptive action. 
In the formalin test, there is a biphasic nociceptive response: an 
immediate and intense response characterized by direct activation of 
sensory fibers (early phase: 0–5 min); a prolonged tonic response phase 
related to the functional changes in the spinal cords dorsal horn and the 
production and release of numerous inflammatory mediators in the 
peripheral tissue (late phase: 15–30 min) (Dubuisson and Dennis, 1977; 
Tjølsen et al., 1992). In general, drugs acting on the central system 
inhibit these phases, whereas the peripherally acting ones inhibit only 
the early phase. 
The results obtained from these analgesic tests suggest that S. chudaei 
infusion has peripheral and central analgesic activity. Rosmarinic acid 
may be the responsible, once it was proven to attenuate both central and 
peripheral pain involving opioid receptors. It may reduce the liberation 
of inflammatory mediators (see anti-inflammatory part (3.4.)) or 
directly block receptors (Boonyarikpunchai et al., 2014). Moreover, 
rosmarinic acid orally administered produces a significant and 
dose-dependent nociceptive response inhibition in mice paw 
glutamate-induced nociception (Guginski et al., 2009). In addition, 
rosmarinic acid showed a decrease of inflammatory and oxidative 
markers (COX-2, PGE-2, NO, IL-1β) in the spinal cord levels (Rahbardar 
et al., 2017). 
Another study reported rosmarinic acid pain reduction only in the 
formalin test late phase (Falcão et al., 2016). Furthermore, kaempferol 
glycosides may display also an analgesic effect. After oral administra-
tion, they showed a potent analgesic and anti-inflammatory effect in 
mice (De Melo et al., 2009). 
4. Conclusions 
This is the first work about phenolic compounds composition, anti- 
inflammatory, and analgesic effect of the infusion of Salvia chudaei 
Batt. & Trab. The infusion has a remarkable antioxidant and anti- 
inflammatory activities, with analgesic effects in both central and pe-
ripheral models. The rosmarinic acid seems to be the main compound 
justifying such effects. Thus, the biological activities of S. chudaei aerial 
parts infusion may be due to the ability of phenolic compounds to inhibit 
inflammatory mediator generation, to act as radical scavenging, and to 
block directly the nociceptive receptors. The results of this study support 
the folk use of Salvia chudaei to treat inflammation and pain. However, 
more tests are needed to completely understand the mechanisms of 
action. 
Author contributions 
All authors were involved in the writing and design of this study. R.S. 
performed experiments and drafted the manuscript. S.M. contributed to 
TPC, TFC, DPPH•, and FRAP experiments. L.B. and I.C.F.R.F. provided 
LC-MS analysis. S.O. and M.B.P.P.O. designed and supervised the study, 
and revised the manuscript. All authors read and approved the final 
version of the manuscript. 
Declaration of competing interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
Acknowledgements 
We thank the University of Porto for receiving R.S. and the MARE 
Table 5 
Effect of S. chudaei infusion on constrictions number of acetic acid-induced 
writhing test in mice.  
Group (n = 6) Dose (mg/kg 
b.w.) 
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Hernández-Saavedra, D., Pérez-Ramírez, I.F., Ramos-Gómez, M., Mendoza-Díaz, S., 
Loarca-Pina, G., Reynoso-Camacho, R., 2016. Phytochemical characterization and 
effect of Calendula officinalis, Hypericum perforatum, and Salvia officinalis 
infusions on obesity-associated cardiovascular risk. Med. Chem. Res. 25 (1), 
163–172. 
Hunskaar, S., Fasmer, O.B., Hole, K., 1985. Formalin test in mice, a useful technique for 
evaluating mild analgesics. J. Neurosci. Methods 14 (1), 69–76. 
Kamatou, G.P., Viljoen, A.M., Steenkamp, P., 2010. Antioxidant, antiinflammatory 
activities and HPLC analysis of South African Salvia species. Food Chem. 119 (2), 
684–688. 
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growing in Algeria. Afr. J. Tradit., Complementary Altern. Med. 13 (1), 71–75. 
Satyanarayana, P.S., Jain, N.K., Singh, A., Kulkarni, S.K., 2004. Isobolographic analysis 
of interaction between cyclooxygenase inhibitors and tramadol in acetic acid- 
induced writhing in mice. Prog. Neuro Psychopharmacol. Biol. Psychiatr. 28 (4), 
641–649. 
Schnitzler, P., Nolkemper, S., Stintzing, F., Reichling, J., 2008. Comparative in vitro 
study on the anti-herpetic effect of phytochemically characterized aqueous and 
ethanolic extracts of Salvia officinalis grown at two different locations. 
Phytomedicine 15 (1–2), 62–70. 
Sekkoum, K., Cheriti, A., Taleb, S., Bourmita, Y., Belboukhari, N., 2011. Traditional 
phytotherapy for urinary diseases in Bechar district (south west of Algeria). Electron. 
J. Environ. Agric. Food Chem. 10 (8), 2616–2622. 
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